Q-Line Biotech Limited

The future of the Indian IVD industry is promising. With continued advancements in diagnostic technologies, greater adoption of automation and digital health solutions, and a focus on accessibility, the industry is well-positioned for sustained growth. As India continues to evolve into a global player in diagnostics, its ability to provide affordable and high-quality solutions will be a critical factor in shaping the future of healthcare both domestically and internationally. The demand for rapid, accurate, and personalized diagnostic solutions will drive the industry forward, with a strong focus on preventative care, early detection, and disease management.

## Competitive Landscape

### ➤ Q-Line Biotech Limited

Q-Line Biotech has been operating in the Indian IVD industry since 2013, offering a range of products such as haematology POC testing, molecular diagnostics, special diagnostics, ELISA, and rapid tests. The company focuses on the indigenous manufacturing of biochemistry reagents and consumables, rapid cards, in-vitro diagnostics (IVD), and pathology equipment. The company has a wide distribution network across India, aiming to provide products at standard prices while driving innovation in diagnostics and healthcare.

Q-Line's sales revenue showed a significant shift pre, during, and post-COVID-19, reflecting its crucial contributions during the pandemic. Pre-COVID, the company recorded sales of INR 943.59 million in FY19. The company developed ICMR-approved COVID-19 testing products, oxygen concentrators, launched mobile testing units, and expanded diagnostic capabilities to support national healthcare needs. As of FY24, the company has recorded the sales of the 2,696 million.

<table><thead><tr><th></th><th>Unit</th><th>FY23</th><th>FY24</th><th>FY25</th></tr></thead><tbody><tr><td>Revenue</td><td>Rs. Million</td><td>1827</td><td>2036</td><td>3138</td></tr><tr><td>Revenue Growth</td><td>%</td><td></td><td>11%</td><td>54%</td></tr><tr><td>Operating Profit</td><td>Rs. Millions</td><td>337</td><td>380</td><td>574</td></tr><tr><td>Operating Margins</td><td>%</td><td>18%</td><td>19%</td><td>18%</td></tr><tr><td>PAT</td><td>Rs Million</td><td>321</td><td>344</td><td>281</td></tr><tr><td>PAT Margins</td><td>%</td><td>17%</td><td>17%</td><td>9%</td></tr><tr><td>Debt Equity</td><td>Times</td><td>0.6</td><td>0.6</td><td>0.9</td></tr><tr><td>Return on Equity</td><td>%</td><td>25%</td><td>21%</td><td>15%</td></tr><tr><td>Return on Assets</td><td>%</td><td>13%</td><td>10%</td><td>6%</td></tr><tr><td>Return on Capital Employed</td><td>%</td><td>23%</td><td>19%</td><td>21%</td></tr></tbody></table>

Source: Company Reports

### ➤ J Mitra & Co

J Mitra & Co. manufactures a wide range of in vitro diagnostic kits and reagents, specializing in diagnostic tests for infectious diseases, diabetes, cardiovascular conditions, and pregnancy. The company operates a production facility capable of manufacturing 5 lakh test kits daily, which equates to 1 crore test kits per month. With a focus on quality and innovation, J Mitra continuously introduces new products to meet evolving healthcare needs, establishing its presence in both the Indian and international diagnostics markets.

<table><thead><tr><th></th><th>Unit</th><th>FY23</th><th>FY24</th></tr></thead><tbody><tr><td>Revenue</td><td>Rs. Million</td><td>1,603</td><td>1,936</td></tr><tr><td>Revenue Growth</td><td>%</td><td></td><td>21%</td></tr><tr><td>Operating Profit</td><td>Rs. Millions</td><td>638</td><td>811</td></tr><tr><td>Operating Margins</td><td>%</td><td>40%</td><td>42%</td></tr><tr><td>PAT</td><td>Rs Million</td><td>481</td><td>626</td></tr><tr><td>PAT Margins</td><td>%</td><td>30.00%</td><td>32.3%</td></tr><tr><td>Debt Equity</td><td>Times</td><td>-</td><td>-</td></tr><tr><td>Return on Equity</td><td>%</td><td>14.0%</td><td>15.0%</td></tr><tr><td>Return on Assets</td><td>%</td><td>14%</td><td>15%</td></tr><tr><td>Return on Capital Employed</td><td>%</td><td>19%</td><td>20.0%</td></tr></tbody></table>

Source: Company Reports

### ➤ Transasia Bio-Medicals Limited

Transasia Bio-Medicals Limited offers a wide range of diagnostic products including haematology reagents, clinical chemistry, and immunoassays. The company manufactures diagnostic instruments and provides integrated solutions for healthcare.